Synthomer Past Earnings Performance
Past criteria checks 0/6
Synthomer's earnings have been declining at an average annual rate of -21.3%, while the Chemicals industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 10.6% per year.
Key information
-21.3%
Earnings growth rate
-24.4%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 10.6% |
| Return on equity | -16.5% |
| Net Margin | -7.1% |
| Next Earnings Update | 12 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Synthomer makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 2,231 | -159 | 167 | 0 |
| 31 Mar 23 | 2,307 | -92 | 166 | 0 |
| 31 Dec 22 | 2,384 | -25 | 166 | 0 |
| 30 Jun 22 | 2,143 | 80 | 171 | 0 |
| 31 Mar 22 | 2,143 | 139 | 171 | 0 |
| 31 Dec 21 | 2,144 | 198 | 172 | 0 |
| 30 Sep 21 | 2,235 | 213 | 187 | 0 |
| 30 Jun 21 | 2,141 | 217 | 183 | 0 |
| 31 Mar 21 | 1,892 | 110 | 183 | 0 |
| 31 Dec 20 | 1,644 | 3 | 183 | 0 |
| 30 Sep 20 | 1,537 | 14 | 141 | 0 |
| 30 Jun 20 | 1,430 | 24 | 100 | 0 |
| 31 Mar 20 | 1,445 | 54 | 100 | 0 |
| 31 Dec 19 | 1,459 | 85 | 100 | 0 |
| 30 Sep 19 | 1,503 | 81 | 108 | 0 |
| 30 Jun 19 | 1,548 | 77 | 116 | 0 |
| 31 Mar 19 | 1,583 | 89 | 116 | 0 |
| 31 Dec 18 | 1,619 | 100 | 116 | 0 |
| 30 Sep 18 | 1,581 | 101 | 115 | 0 |
| 30 Jun 18 | 1,544 | 102 | 113 | 0 |
| 31 Mar 18 | 1,512 | 88 | 114 | 0 |
| 31 Dec 17 | 1,480 | 74 | 114 | 0 |
| 30 Sep 17 | 1,425 | 90 | 106 | 0 |
| 30 Jun 17 | 1,370 | 105 | 99 | 0 |
| 31 Mar 17 | 1,208 | 108 | 99 | 0 |
| 31 Dec 16 | 1,046 | 110 | 99 | 0 |
| 30 Sep 16 | 954 | 95 | 88 | 0 |
| 30 Jun 16 | 862 | 79 | 77 | 0 |
| 31 Mar 16 | 866 | 70 | 76 | 0 |
| 31 Dec 15 | 870 | 60 | 76 | 0 |
| 30 Sep 15 | 892 | 56 | 66 | 0 |
| 30 Jun 15 | 913 | 51 | 56 | 0 |
| 31 Mar 15 | 925 | 48 | 56 | 0 |
| 31 Dec 14 | 936 | 45 | 56 | 0 |
| 30 Sep 14 | 941 | 46 | 58 | 0 |
| 30 Jun 14 | 946 | 46 | 59 | 0 |
| 31 Mar 14 | 970 | 47 | 59 | 0 |
| 31 Dec 13 | 993 | 48 | 59 | 0 |
| 30 Sep 13 | 1,000 | 51 | 62 | 0 |
| 30 Jun 13 | 1,007 | 53 | 64 | 0 |
| 31 Mar 13 | 1,030 | 53 | 65 | 0 |
| 31 Dec 12 | 1,053 | 53 | 65 | 0 |
Quality Earnings: 7YC is currently unprofitable.
Growing Profit Margin: 7YC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7YC is unprofitable, and losses have increased over the past 5 years at a rate of 21.3% per year.
Accelerating Growth: Unable to compare 7YC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 7YC is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-34.6%).
Return on Equity
High ROE: 7YC has a negative Return on Equity (-16.52%), as it is currently unprofitable.